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ABSTRACT Brucellosis is a bacterial disease of animals and humans. Brucella abor-
tus barely activates the innate immune system at the onset of infection, and this
bacterium is resistant to the microbicidal action of complement. Since complement
stands as the ﬁrst line of defense during bacterial invasions, we explored the role of
complement in B. abortus infections. Brucella abortus-infected mice depleted of com-
plement with cobra venom factor (CVF) showed the same survival rate as mice in
the control group. The complement-depleted mice readily eliminated B. abortus
from the spleen and did so more efﬁciently than the infected controls after 7 days
of infection. The levels of the proinﬂammatory cytokines tumor necrosis factor alpha
and interleukin-6 (IL-6) remained within background levels in complement-depleted
B. abortus-infected mice. In contrast, the levels of the immune activator cytokine
gamma interferon and the regulatory cytokine IL-10 were signiﬁcantly increased. No
signiﬁcant histopathological changes in the liver and spleen were observed between
the complement-depleted B. abortus-infected mice and the corresponding controls.
The action exerted by Brucella on the immune system in the absence of comple-
ment may correspond to a broader phenomenon that involves several components
of innate immunity.
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Brucella organisms are facultative extracellular-intracellular bacteria of animals andhumans that establish chronic infections (1). Brucella abortus avoids activating the
innate immune system at the onset of the infection (2–5). This phenomenon is due to
the absence and modiﬁcation of the Brucella pathogen-associated molecular patterns,
which result in the weak activation of pattern recognition receptors (2, 3, 5–8). The lack
of obvious clinical signs and symptoms at early stages of Brucella infections in animals
and humans is in accordance with this model (5, 9).
The absence of polymorphonuclear leukocytes (PMNs) promotes the elimination of B.
abortus in mice by favoring the Th1 over the Th2 immune response (4). This supports the
proposal that innate immune recognition is hampered at the onset of the infection and that
PMNs play a regulatory role in the adaptive immune response in brucellosis (4).
The complement system is a cascade of various elements of innate immunity and
the ﬁrst line of defense against microorganisms. Complement activation has three main
functions: opsonization of invaders, ampliﬁcation of the immune response through
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recruitment of inﬂammatory cells, and directing of the killing of microorganisms (10).
Pathogens have developed different strategies to evade complement killing or activa-
tion (11, 12). Virulent Brucella organisms resist the killing action of complement and
induce low levels of activation of the complement cascade (13–15). In spite of this, the
role of complement during brucellosis in vivo has not been explored. Here, we
demonstrate that the removal of complement promotes the elimination of B. abortus
in mice at early times of infection, suggesting a regulatory role of this system during
brucellosis.
RESULTS AND DISCUSSION
B. abortus does not kill mice depleted of complement with CVF. C3 knockout
mice display innate and diverse long-lasting immunological defects (16–18) that may
hamper the examination of the role of complement in brucellosis. To circumvent this,
we have used the cobra venom factor (CVF) complement depletion model. CVF is a
three-chain protein that structurally resembles C3c, one of the degradation products of
C3b, but is unable to form a C3/C5 convertase (19). After intraperitoneal (i.p.) injection
of CVF, the C3 component was not detected in the serum of mice (Fig. 1A). Comple-
ment depletion did not alter the leukocyte count or cell proﬁles in mice (Fig. 1B). We
recorded reduced survival rates for complement-depleted mice infected with Salmo-
nella enterica in comparison to those for the infected control group (Fig. 1C). This
observation is consistent with previous works showing that CVF complement depletion
in vivo exacerbates bacterial infections and lethality (20, 21). In contrast, complement-
depleted mice infected with B. abortus displayed the same survival rate as B. abortus-
infected control mice (Fig. 1D). Complement-depleted mice infected with B. abortus
FIG 1 B. abortus is not lethal in complement-depleted mice. Groups of BALB/c mice were chronically
depleted of complement by means of repeated injections of CVF. (A) Serum C3 detection by Western
blotting was used to determine the depletion of complement (Cdepl) in CVF-injected mice. Arrows
indicate the position of the C3 fraction and its fragments. (B) Percentage of leukocyte types in
complement-depleted mice (n  5) and PBS-injected control mice (n  5). Lymph, lymphocytes; Mono,
monocytes. (C) Survival percentage of PBS-injected control mice (n 7) and complement-depleted mice
(n  7) after infection with S. enterica. (D) Survival percentage of PBS-injected control mice (n  7) and
complement-depleted mice (n 7) after infection with B. abortus 2308W. Black and white bars represent
the median interquartile range (IQR). The Mann-Whitney U test showed no signiﬁcant differences. Data
are representative of those from at least three independent experiments.
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did not show any behavior changes or weight loss throughout the duration of the
experiment.
The absence of complement favors the removal of B. abortus. In order to
determine if the acute absence of complement alters the course of Brucella infection,
we performed bacterial counts in the spleen. As demonstrated in Fig. 2A, the spleen
weights were not statistically signiﬁcantly different between the complement-depleted
and control B. abortus-infected mice (Fig. 2A). In contrast, the number of bacteria in the
spleens of complement-depleted infected mice was signiﬁcantly lower than that in the
spleens of the control infected group (Fig. 2B). As shown in Fig. 2C and D, we did not
detect differences in spleen weights or bacterial clearance between the aspercetin-
treated and B. abortus-infected mice and the phosphate-buffered saline (PBS)-treated
control mice. This result is consistent with our previous experience demonstrating that
the repeated administration of a sole foreign immunogenic protein does not alter the
course of B. abortus infection in mice (22), therefore ruling out an adjuvant effect by the
early induction of the adaptive immune response.
Complement-depleted B. abortus-infected mice produce higher levels of pro-
inﬂammatory cytokines. In order to evaluate the proinﬂammatory response of
complement-depleted Brucella-infected mice after 7 days of infection, quantitation of
cytokines was performed (Fig. 3). The amounts of tumor necrosis factor alpha (TNF-)
and interleukin-6 (IL-6) remained close to the background levels. In contrast, the
quantities of gamma interferon (IFN-) as well as the regulatory cytokine IL-10 were
signiﬁcantly higher in the infected complement-depleted mice (Fig. 3). This cytokine
proﬁle is similar to the one induced in Brucella-infected mice depleted of PMNs (4).
Complement depletion does not inﬂuence the pathology in B. abortus-infected
mice. As expected, S. enterica, used for comparative purposes, induced a severe
acute inﬂammation in the spleen and liver of complement-depleted mice at 7 days of
infection (Fig. 4A). In contrast, B. abortus-infected complement-depleted mice demon-
strated chronic inﬂammation with granuloma formation (Fig. 4B) indistinguishable from
FIG 2 The absence of complement favors the removal of B. abortus. (A) Groups of seven BALB/c mice
were depleted of complement or injected with PBS and then infected with 0.1 ml of B. abortus 2308W
at 106 CFU/ml by the i.p. route. At 7 days postinfection, the spleen weight and bacterial counts were
determined for each group. (B) To ensure that CVF did not prime an adjuvant immune response,
promoting bacterial clearance, groups of seven BALB/c mice were treated with repeated i.p. injections of
80 g of aspercetin or with PBS and then infected with 0.1 ml of B. abortus 2308W at 106 CFU/ml by the
i.p. route. (C and D) At 7 days postinfection the spleen weight (C) and bacterial counts (D) were
determined for each group. The median is represented by a line. Statistical signiﬁcance was calculated
by the Mann-Whitney U test. *, P 0.05. Data are representative of those from at least three independent
experiments.
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that in B. abortus-infected mice not depleted of complement (Fig. 4A). Although little
vasodilation and hyperemia were observed in the liver and spleen of noninfected
C3-depleted mice, the histopathological effect observed in the B. abortus-infected mice
was not due to the action of CVF (Fig. 4A).
At the onset of infection, Brucella follows a stealthy strategy, taking advantage of an
immunological window to invade the host cells and disperse throughout the reticu-
loendothelial system (1, 3, 5). During infection, Brucella interacts with a variety of serum
proteins, such as antibodies and complement components, that selectively bind to the
bacterium surface (22). Regardless of this, Brucella resists the killing action of comple-
ment and does not fully activate the complement cascade (13–15). Interestingly, these
two complement activities vary depending upon the animal species: human serum
opsonizes better and is more bactericidal than mouse serum (22). In spite of this,
complement still plays a relevant role in vivo in the mouse model during the acute
phase of Brucella infection, as shown here. From our results, we propose that Brucella
hampers the opsonizing, killing, and chemotactic functions of complement by C3
convertase modulation and does so independently if activation is related to the
alternative pathway at the onset of the infection or if activation is related to the classical
pathway in later stages to sustain persistence.
It is worth noting the parallelism observed between the complement depletion
model, used in this work, and the PMN depletion model, used previously during B.
abortus infections (4). Indeed, in both murine models, the cytokine proﬁle is similar and
B. abortus is more efﬁciently eliminated from the spleen. It seems that in both systems,
FIG 3 Complement-depleted B. abortus-infected mice produce higher levels of proinﬂammatory cyto-
kines. Cytokine levels in sera from complement-depleted (n  7) and control (n  7) mice were
determined by ELISA after 7 days of infection with 0.1 ml of B. abortus 2308W (Ba 2308) at 106 CFU/ml
by the i.p. route. A group of noninfected complement-depleted mice (n  5) was used as a control. The
mean is represented as a line. Asterisks above the bars indicate statistically signiﬁcant differences relative
to complement-depleted noninfected mice. Statistical signiﬁcance was calculated by ANOVA and Tukey’s
multiple-comparison test. **, P 0.01; ***, P 0.001. Data are representative of those from at least three
independent experiments.
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the regulatory mechanism of the adaptive immune response during brucellosis is
released after removal of complement or PMNs (4). This is not totally unexpected, since
both elements cross talk during the innate immune response (23).
Bacterial infections inducing low inﬂammatory responses (as is the case in brucel-
losis) drive the production of IL-10 by naturally occurring regulatory T cells (nTregs) (24).
In the course of the infection, this allows pathogens to escape from the immune
control, preventing pathology and favoring pathogen persistence (24). It may be that
the Brucella-infected complement-depleted mice induced adaptive nTregs with the
ability to promote the synthesis of IFN-, IL-12, and IL-10. Moreover, it is well-known
that complement depletion hampers the arrival of inﬂammatory cells, including PMNs,
in injured animals (25). Therefore, complement and PMNs are key components of innate
immunity, and the efﬁcient removal of B. abortus from the spleen of complement-
depleted mice and PMN-depleted mice may be due to the higher levels of production
of IFN- and IL-12, which are the most relevant cytokines in brucellosis (26). Interest-
ingly, mice lacking B cells, which are mainly elements of the adaptive immune response,
also favor the removal of Brucella by increasing IFN- levels (27). This particular immune
response may favor the positive balance of the Th1 immune response and the sup-
pression of downstream pathologies, as seen for other microbes (28, 29). This proposal
is in tune with our previous proposal resulting from ﬁndings obtained with the PMN
depletion model (4). Although we do not know the mechanism exerted by Brucella, it
seems that it corresponds to a broader phenomenon that involves several components
of the innate immune system.
FIG 4 Complement-depleted B. abortus-infected mice show a histopathological proﬁle similar to that of
the control PBS-injected B. abortus-infected mice. (A) The semiquantitative pathological index was
determined by histopathological observation of the spleen and liver from complement-depleted mice
(n  7) and control mice (n  7) after 7 days of infection with 0.1 ml of 106 B. abortus bacteria or 3 days
of infection with 103 S. enterica bacteria. (B) Histopathological examination of the liver and spleen of
complement-depleted B. abortus-infected mice after 7 days of infection. The arrows indicate the
characteristic granulomas induced by Brucella in the liver and spleen (35). Data are representative of
those from at least three independent experiments.
B. abortus in a Murine Complement Depletion Model Infection and Immunity












Ethics statement. The protocols for mouse experimentation were approved by the Comité Institu-
cional para el Cuido y Uso de los Animales of the Universidad de Costa Rica (CICUA-019-16, CICUA-067-
17). These protocols were in agreement with the corresponding law, Ley de Bienestar de los Animales,
of Costa Rica (Law 9458 on animal welfare). Mice were housed in the Animal Building of the Veterinary
Medicine School, Universidad Nacional, Costa Rica. All of the animals were kept in cages with water and
food ad libitum under biosafety containment conditions before and during the experiment.
Mouse strains and infection protocols. CVF was puriﬁed from the venom of the Naja naja cobra
as described elsewhere (30). Female BALB/c mice (weight, 18 to 21 g) were depleted of complement by
intraperitoneal (i.p.) injection of CVF at 0.8 g/g body weight/mouse in 0.1 ml PBS (20) following the
protocol described in Fig. 5. Controls and complement-depleted mice were i.p. infected with 0.1 ml of
PBS containing 106 CFU/ml of the virulent strain B. abortus 2308W (31) or 103 CFU of Salmonella enterica
serovar Typhimurium strain SL1344 (Fig. 5). A group of mice was injected with CVF only to ensure that
the effects seen in infected mice were not only due to the CVF injection. Controls were injected with 0.1
ml sterile PBS. Complement depletion was conﬁrmed by the absence of the C3 protein by Western
blotting using polyclonal C3 antibody (catalog number ab14232; Abcam) in combination with goat
anti-mouse IgG (HL)-horseradish peroxidase for detection (Thermo Fisher Scientiﬁc). Complement
depletion was continued for 7 and 10 days after infection, as indicated in the time course protocol
presented in Fig. 5.
Heat-inactivated CVF is not a suitable antigenic control. Like many other proteins related to
complement, the CVF protein is thermolabile and breaks down into many small peptides with low
immunogenicity. Therefore, to ensure that the immune response adjuvant effect against a foreign
protein was not promoting B. abortus clearance, a second group of mice was treated with aspercetin, a
low-molecular-weight protein from the venom of the Bothrops asper snake that depletes platelets via the
de Hageman factor (32). Brieﬂy, BALB/c mice were depleted through the i.p. injection of 80 g of puriﬁed
aspercetin protein in 0.1 ml PBS. Then, platelet-depleted mice were i.p. infected with 0.1 ml of PBS
containing 106 CFU/ml of virulent Brucella abortus 2308W at 6 h after depletion. Platelet-depleted mice
were again i.p. injected with the same dose of aspercetin at 24 and 48 h postinfection. Controls were
injected with 0.1 ml sterile PBS. A group of mice was injected with aspercetin only to ensure that the
effects seen in infected mice were not due to the injection of aspercetin. Platelet depletion was
conﬁrmed with a VetScan HM5 hematology analyzer (Abaxis). Mice were sacriﬁced at 7 days postinfec-
tion to perform CFU counts.
Bacterial counts, cytokine quantitation, and histopathology. Spleens were collected, weighed,
and homogenized in sterile PBS, and bacterial counts were estimated as described elsewhere (33). Blood
was collected from the mice, and serum was kept at 80°C until it was used. Murine levels of IL-6, IL-10,
IL-12, IFN-, and TNF- were measured using mouse enzyme-linked immunosorbent assay (ELISA)
Ready-Set-Go! kits (Affymetrix; eBioscience) according to the manufacturer’s speciﬁcations. A pool of
serum from healthy BALB/c mice was used for background estimation. For histopathological studies, the
spleens and livers of the mice were ﬁxed in 10% neutral buffered formalin, processed, stained with
hematoxylin and eosin or Giemsa stain as described elsewhere (34), and then observed under a
microscope.
Statistical analysis. We used GraphPad Prism software (La Jolla, CA, USA) to statistically analyze our
results. The Mann-Whitney test was used for comparison of the cell proﬁles of mice that had been
complement depleted with CVF and control mice, as well as the spleen weights and CFU of complement-
depleted or platelet-depleted and control Brucella-infected mice. Analysis of variance (ANOVA) followed
by Tukey’s multiple-comparison test was used for comparison of cytokine levels among mice comple-
ment depleted with CVF, complement-depleted mice, and control Brucella-infected mice. P values of
0.05 were considered to represent a statistically signiﬁcant difference.
FIG 5 Protocol for depletion of complement with CVF in mice. CVF (0.8 g/g body weight) was
administered intraperitoneally at different times before and after bacterial infections (thin arrows).
Bacteria were inoculated at time zero (broken arrow). Bacterial counts, cytokine estimation, and histo-
pathological studies were performed at 7 days of infection (bent arrow). The end of the survival
experiment is indicated with a thick arrow.
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